Home โ†’ Blog โ†’ Amazon FBA Prep for OTC Drugs and Over-the-Counter Medicine: The Complete 2026 Compliance Guide for Sellers

Amazon FBA Prep for OTC Drugs and Over-the-Counter Medicine: The Complete 2026 Compliance Guide for Sellers

November 15, 2026

Most FBA prep guides treat over-the-counter drugs as a slightly stricter version of beauty products. That gap is exactly why FDA has sent Amazon three formal warning letters in four years - the most recent in October 2026 - citing FBA as the distribution mechanism for unapproved drug products. If you sell sunscreen, hand sanitizer, ibuprofen, acne treatments, or any other OTC medication through FBA, the compliance framework is not supplements-plus. It is pharmaceutical regulation with federal misbranding liability attached to every label decision a prep center makes on your behalf.

OTC Drug vs. Dietary Supplement: The Regulatory Split That Changes Every Step

A product is an OTC drug if it claims to diagnose, cure, treat, mitigate, or prevent a disease or condition - or if it contains an active ingredient already recognized as a drug under a federal OTC monograph or approved application. Aspirin, benzoyl peroxide, zinc oxide in sunscreen, and ethanol in hand sanitizer all trigger drug status regardless of how the packaging frames the marketing.

A dietary supplement is governed by DSHEA and must make only structure-or-function claims without implying disease treatment. These two categories operate under entirely different regulatory regimes, and confusing them is the most common source of OTC listing failures on Amazon.

FactorOTC DrugDietary Supplement
Governing GMPsPharmaceutical manufacturing (21 CFR Part 211)Supplement manufacturing (21 CFR Part 111)
Required label panelDrug Facts - mandated format and sequenceSupplement Facts - mandated format
FDA market authorizationNDA, ANDA, or OTC monograph complianceDSHEA notification for new dietary ingredients
Product identifierNDC (National Drug Code) requiredNo equivalent identifier required
Amazon category gateDrugs - hard gate, requires ungatingHealth & Beauty - lower documentation threshold

The GMP distinction matters for prep because pharmaceutical manufacturing standards require documented lot tracking and expiration dating at every stage of the supply chain. If your contract packager operates only under supplement GMPs, the product's regulatory status may already be compromised before it reaches a prep facility. Confirm that every manufacturer in your supply chain holds a current FDA drug establishment registration - not just a supplement facility registration.

Which Products Are Actually OTC Drugs on Amazon

Amazon's Drugs sub-category gate catches many sellers who assume they are operating in a different category. These product types are regulated as OTC drugs and require full ungating approval before listing:

  • Sunscreens - including SPF-rated lip balms and moisturizers with any SPF claim, regulated under the FDA's sunscreen monograph
  • Hand sanitizers containing ethanol or isopropyl alcohol as the active ingredient
  • Acne treatments based on benzoyl peroxide, salicylic acid, or sulfur
  • Topical analgesics containing lidocaine, high-concentration menthol, or capsaicin
  • Pain relievers - aspirin, ibuprofen, acetaminophen, and naproxen sodium in any dose form
  • Topical antiseptics for wound care
  • Antifungal treatments based on clotrimazole, miconazole, or terbinafine
  • Combination drug-device products - medicated bandages, drug-eluting wound dressings, and acne devices that deliver a drug ingredient through a device mechanism

Combination drug-device products carry an additional requirement: a 510(k) clearance alongside standard OTC drug documentation. If your product physically delivers a drug through a device mechanism, verify with your regulatory counsel whether the device component has been cleared before attempting to ungate on Amazon.

The products that most often surprise sellers are SPF moisturizers and medicated lip balms. Many beauty brands launch these as cosmetics without recognizing that any SPF claim converts the product to an OTC drug under federal law. Amazon will reject these at the category gate or suppress the listing after the fact.

NDC Codes and SPL Drug Listings: Who Registers What

Every OTC drug sold via FBA needs a National Drug Code - a unique identifier structured in three segments that identify the labeler, the product, and the package size. The NDC is not just a tracking number. Amazon requires a valid NDC and an active Structured Product Labeling drug listing in the FDA's National Drug Code Directory before a Seller Central OTC listing will be approved.

How to Get an NDC Labeler Code

The NDC labeler code is assigned to the firm responsible for labeling the product, not necessarily the manufacturer. Any company that places its own name or brand on an OTC drug package must obtain its own labeler code from FDA through the SPL submission process. Once a code is assigned, the firm must submit and maintain an SPL drug listing in the FDA database, updated any time the formulation, dosage form, or labeling changes.

The SPL listing must also reflect the current formulation. The CARES Act's OTC monograph modernization, effective from 2020, allows manufacturers to update monograph-compliant formulations through an Administrative Order process instead of full rulemaking. Amazon still requires the SPL listing in the FDA database to reflect any formulation change before the updated product can be listed in Seller Central. If you reformulate a monograph drug - changing concentration or adding an inactive ingredient - update the SPL before shipping the new product to FBA, not after.

FDA Establishment Registration and Annual Renewal

Every domestic drug manufacturer, repackager, and relabeler must register its facility with FDA. That registration must be renewed every year during a window that runs from October 1 through December 31. A registration that lapses - even for a manufacturer that has been in good standing for years - invalidates the associated NDC listings and can trigger an Amazon listing suspension for every product tied to that registration, with no action required from Amazon's side. The suspension happens automatically when Amazon's compliance systems detect the lapsed status in the FDA database.

This is an inventory risk most sellers do not anticipate. If your manufacturer misses the annual renewal window, your products become non-compliant mid-season without any action on your part. Before building a new FBA shipment - especially for high-volume items like pain relievers or sunscreens ahead of Q4 - verify your manufacturer's registration is current. The FDA's FEI Search tool, publicly accessible at FDA.gov, lets you check any registered facility's current status and renewal date before you ship.

If you use multiple contract manufacturers across different SKUs, track each registration expiration independently. A lapsed registration on one manufacturer does not affect products from other facilities, but consolidating this tracking into a pre-shipment checklist prevents surprises at the worst time of year.

Amazon's OTC Ungating Process

Amazon's Drugs sub-category is a hard gate - no OTC unit can be listed until approval is granted. The process runs through Seller Central's category approval pathway and typically resolves within roughly a week to two weeks, though timelines vary. For multiple SKUs from the same manufacturer, you can submit them together in a single ungating request with shared manufacturing documentation to avoid repeating the process for each ASIN.

  1. Obtain FDA establishment registration documents from your manufacturer - the registration number and confirmation that the renewal is current for the present calendar year.
  2. Gather purchase invoices from the manufacturer or an FDA-registered wholesaler. Invoices must show your business name, the product name, and a quantity meeting Amazon's minimum unit requirement - check current Seller Central help for the exact threshold, as this can change. Invoices must be dated within the last 180 days.
  3. Collect NDC proof: either the FDA NDC Directory listing page for each product or the full SPL file. The NDC on the invoice must match the NDC in the SPL submission exactly.
  4. Gather Certificates of Analysis for each product batch. For standard monograph drugs, Amazon accepts a CoA per batch rather than a full NDA or ANDA document, provided the product fully complies with the monograph.
  5. Submit all documentation through Seller Central under Health & Beauty > Drugs. Amazon's review team verifies each document against the FDA database, so discrepancies between your submission and the live database will cause delays rather than outright rejection.
  6. After approval, repeat the NDC verification step each time you add a new SKU or reformulate an existing one - ungating is per-account, but listing accuracy is per-ASIN and must be maintained independently.

If your products carry an NDA or ANDA rather than relying on a monograph, include the approval letter or the FDA's drug application database entry as supplementary documentation. Amazon's category team is more accustomed to monograph products and may request additional review time for NDA/ANDA submissions.

Drug Facts Label Compliance

The Drug Facts panel is not optional and not negotiable in its format. Federal OTC labeling regulations under 21 CFR ยง201.66 require a boxed format with a hairline barline around the entire panel, a white or visually contrasting background, and a minimum type size for all text. Check the regulation directly for the current type size specification - the exact point size is a regulatory parameter you should confirm from the source rather than from a prep guide. The title "Drug Facts" must be set in a type size larger than any other text on the panel.

Required Headings in Mandatory Order

These headings must appear exactly as listed, in this sequence, with no omissions or reordering:

  • Active Ingredient(s) - with the quantity per dose and therapeutic purpose on the same line
  • Purpose
  • Uses
  • Warnings - including "Do not use," "Ask a doctor," "Stop use and ask a doctor," and applicable pregnancy or nursing statements
  • Directions
  • Other Information - including required storage conditions
  • Inactive Ingredients

For small packaging where a continuous panel is not practical, the regulation permits a split Drug Facts panel - with one portion on the principal display panel and the continuation marked as "Drug Facts (continued)." If your product uses this format, every section of the split panel must remain readable and unobstructed after all prep work is applied, including poly bagging and label application.

FNSKU Placement on OTC Packaging Without Creating a Misbranded Drug

Every OTC drug unit entering FBA requires a unique FNSKU label. Amazon completed the removal of commingled inventory across all categories as of March 31, 2026, so there is no longer any pathway to avoid FNSKU labeling for OTC drugs. The critical variable is not whether to apply the label - it is where.

Safe Zones by Packaging Type

  • Cartons and boxes: apply the FNSKU to a plain panel containing no required labeling - typically the bottom panel or a designated blank side. If no blank panel exists, work with your manufacturer before the artwork is finalized to designate a clear zone.
  • Bottles and tubes: apply to the back panel in a region containing only decorative copy, well below the Drug Facts panel and clear of the NDC barcode area. Lot numbers and expiration dates are often placed near the bottom rim - confirm clearance before applying.
  • Blister cards and foil-backed packs: apply to the reverse side in a designated zone your packaging designer should mark. The lot number and expiration date on many blister packs are embossed directly into the foil - confirm the FNSKU label will not cover embossed marks.
  • Pouches and sachets: use a hang tag or secondary label positioned at the top seal area, away from the principal display panel and Drug Facts.

The most cost-effective fix is structural: build an FNSKU zone into the packaging artwork before printing. Correcting label placement after packaging is printed requires either a custom cover label sized precisely to an empty area or a full packaging reprint - both more expensive than a single decision made during the design phase.

Expiration Dating and Lot Tracking for FBA

OTC drugs have two federally required identifiers that must survive every step of prep: the expiration date and the lot number. The expiration date protects consumers; the lot number enables FDA-mandated recall tracking under 21 CFR ยง211.130. Amazon uses lot codes to process product recalls and removal orders across its warehouse network. A lot number obscured at inbound creates a unit that is effectively invisible in a recall scenario - which is a problem for Amazon, for the FDA, and for your account.

The Lot-Code-Only Problem

Many manufacturers print only a lot code on the bottom of a bottle or carton without printing the actual expiration date in a human-readable format - this is common practice for products made in large batches for retail. Amazon requires expiration dates in MM-DD-YYYY or MM-YYYY format, clearly visible on the unit. A lot code alone does not satisfy this requirement, even if your internal records can decode it to a date. Any OTC unit arriving at a prep center with only a lot code and no printed expiration date needs a corrective label added before the inbound shipment - a label showing the actual date in the required format, applied without covering the lot number itself.

Amazon's expiration date policies include two operational thresholds: one governing how close to expiration a unit can be when it is inbounded, and another governing when a unit already inside the warehouse is flagged for removal or disposal. The specific day counts for each threshold are stated in Amazon's FBA inventory requirements - verify the current figures in Seller Central before shipping, as these policies can be updated. The practical guidance: build a minimum shelf-life buffer well above the inbound threshold into your purchasing and shipping calendar. Units arriving below the inbound cutoff will be refused at the fulfillment center, and those already inside the warehouse that fall below the disposal threshold are either removed at your expense or discarded at Amazon's discretion.

  • Confirm the lot number and expiration date are on the same surface and that no FNSKU or other prep label overlaps either identifier.
  • If poly bagging is required - common for liquids, creams, and multipacks - apply the FNSKU to the outside of the bag and ensure the lot number and expiration date on the product inside remain legible through the bag.
  • For multipacks and bundles, each individual unit inside still needs its lot number and expiration date visible. If bundling obscures this information, add a master label to the bundle showing the soonest expiration date and the lot numbers of all units contained.
  • Document lot and expiration information at the time of prep. Your prep records create the audit trail that matters if a recall is ever processed against your products.

The October 2026 FDA Warning Letter and What It Signals

On October 1, 2026, FDA issued warning letter MARCS-CMS 736006 to Amazon.com, citing nine unapproved drug products sold via FBA - all marketed for STI treatment - as a patient safety risk. The letter specifically named FBA as the distribution mechanism, placing Amazon's fulfillment infrastructure in the enforcement frame alongside the third-party sellers who listed the products.

Three FDA warning letters in four years - October 2022, April 2025, and October 2026 - each citing unapproved drug products distributed through FBA, is not a pattern Amazon can attribute to isolated third-party sellers. The FDA has now documented the platform's role in drug distribution three separate times, and the enforcement trajectory is upward.

What this trajectory means for sellers and prep centers operating in this space:

  • Amazon's category compliance team will almost certainly tighten OTC ungating documentation requirements - expect stricter invoice verification and more frequent SPL database cross-checks as the platform responds to sustained FDA pressure.
  • Products in grey-area categories - especially those making disease treatment claims without a matching monograph or approved application - will face higher rates of ASIN suppression and account-level review.
  • Prep centers that handle OTC drugs without a formal documentation intake process create shared liability exposure. A prep workflow that checks NDC status, SPL currency, establishment registration, and label compliance before accepting a job is not excessive caution at this point - it is the minimum expected standard when the FDA has explicitly named FBA distribution three times in four years.

The practical implication for a compliant seller is counterintuitively positive. FDA enforcement pressure on unapproved products will compress the number of non-compliant competitors operating in these categories. Sellers who have invested in proper NDC registration, establishment registration tracking, and label compliance are building a structural advantage that becomes more durable as enforcement escalates. The documentation burden is real, but it is a one-time investment per product - not a recurring cost on each shipment.

Frequently Asked Questions

Can I sell a foreign OTC drug on Amazon FBA if it is approved in another country?

No. FDA drug approval is specific to the United States, and foreign market authorization - including products approved in Canada, the EU, or Japan - does not satisfy the requirement for FDA approval or OTC monograph compliance. Products without U.S. regulatory authorization are unapproved new drugs and cannot legally be distributed through FBA. If you want to bring a foreign OTC product to the U.S. market, FDA approval or monograph compliance must be established before the first unit ships.

My SPF moisturizer is marketed as a cosmetic - does it really need OTC ungating on Amazon?

Yes. Any product making an SPF claim is regulated as an OTC drug under the FDA's sunscreen monograph, regardless of how else it is marketed. A moisturizer with SPF is simultaneously a cosmetic for its moisturizing function and an OTC drug for its sunscreen function - and the drug regulation governs the entire product. Amazon treats it as an OTC drug in Seller Central and requires full ungating documentation including NDC and SPL proof before the listing can be approved.

What happens to my existing FBA inventory if my manufacturer's FDA establishment registration lapses?

A lapsed registration immediately creates compliance risk for all inventory tied to that manufacturer. Units already inside Amazon's fulfillment network can be subject to listing suspension and removal requests if Amazon's compliance systems detect the lapse through automated SPL database checks. Units still at a prep center or in transit become non-compliant inventory that cannot legally ship to FBA until the registration is renewed. Monitor your manufacturer's annual renewal each fall before the December 31 deadline - a lapse during the holiday selling season is a serious operational risk with no quick fix.

Can my prep center apply FNSKU labels to OTC drug products, or do I have to do it myself?

A prep center can and should apply FNSKU labels - that is the core service. The critical requirement is placement: the FNSKU must land on a compliant location that does not cover the Drug Facts panel, NDC, lot number, or expiration date. Brief your prep center explicitly on these placement restrictions for every OTC SKU, and request photo documentation of label placement on the first batch of any new product. Assuming that a standard placement protocol designed for general merchandise is appropriate for drug products is one of the most common and costly mistakes in OTC FBA prep.

Does the CARES Act's OTC monograph modernization change how I manage Amazon listings after a reformulation?

It changes how the formulation update is filed with FDA - through an Administrative Order rather than full rulemaking - but it does not change Amazon's listing requirements. Amazon checks product data against the live SPL database in the FDA's NDC Directory, not against your internal formulation records. Any formulation change, even one fully compliant with the updated monograph, requires the SPL drug listing to reflect the update before the reformulated product can be listed in Seller Central. Update the SPL first, confirm it appears in the FDA database, then ship the reformulated product - not the other way around.

Need Help with FBA Prep?

Get professional prep services from SNS Prep Center

Contact Us ๐Ÿ“ž